av/glenmark--big.svg

COM:GLENMARKPHARMA

Glenmark Pharmaceuticals

  • Stock

INR

Last Close

1,478.20

25/11 09:40

Market Cap

390.66B

Beta: -

Volume Today

654.54K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
59.24B
-
65.22B
10.09%
75.03B
15.05%
88.64B
18.14%
89.44B
0.90%
97.05B
8.51%
97.05B
0%
108.06B
11.34%
121.74B
12.66%
121.74B
0%
118.13B
2.97%
cost of revenue
19.12B
-
19.66B
2.82%
23.97B
21.93%
26.60B
10.96%
31.10B
16.91%
34.08B
9.58%
34.08B
0%
37.44B
9.87%
44.60B
19.12%
44.60B
0%
78.63B
76.32%
gross profit
40.11B
-
45.56B
13.56%
51.06B
12.08%
62.04B
21.51%
58.34B
5.96%
62.98B
7.94%
62.98B
0%
70.62B
12.14%
77.14B
9.24%
77.14B
0%
39.50B
48.80%
selling and marketing expenses
3.65B
-
5.58B
53.13%
6.58B
17.90%
8.43B
28.03%
7.63B
9.45%
8.71B
14.16%
8.71B
0%
9.80B
12.48%
8.96B
8.51%
8.96B
0%
general and administrative expenses
1.11B
-
1.59B
43.76%
1.93B
21.51%
2.22B
15.02%
2.07B
6.85%
2.75B
33.02%
2.75B
0%
3.17B
15.20%
4.01B
26.30%
4.01B
0%
selling general and administrative expenses
4.75B
-
7.17B
50.95%
8.51B
18.70%
10.65B
25.07%
9.70B
8.91%
11.46B
18.19%
11.46B
0%
12.97B
13.14%
12.97B
0.01%
12.97B
0%
33.36B
157.23%
research and development expenses
14.48B
-
13.19B
-
12.79B
3.03%
other expenses
48.40M
-
204.64M
322.81%
280.42M
37.03%
165.89M
40.84%
129.59M
21.88%
267.61M
106.51%
267.61M
0%
468.65M
75.12%
688.35M
46.88%
45.77B
6,549.84%
8.40B
81.65%
cost and expenses
50.40B
-
56.03B
11.16%
63.55B
13.43%
74.04B
16.50%
76.80B
3.74%
86.66B
12.83%
86.66B
0%
90.90B
4.89%
103.34B
13.69%
103.34B
0%
112.00B
8.38%
operating expenses
31.28B
-
36.37B
16.27%
39.58B
8.83%
47.44B
19.86%
45.71B
3.65%
52.58B
15.04%
52.58B
0%
53.46B
1.67%
58.74B
9.88%
58.74B
0%
33.36B
43.21%
interest expense
1.89B
-
1.90B
0.83%
1.79B
5.92%
2.37B
32.67%
2.86B
20.33%
3.35B
17.17%
3.35B
0%
3.53B
5.54%
2.98B
15.58%
2.98B
0%
5.16B
73.09%
ebitda
11.02B
-
10.44B
5.25%
14.53B
39.10%
20.72B
42.64%
17.09B
17.54%
17.93B
4.94%
17.93B
0%
21.34B
19.01%
24.93B
16.83%
24.93B
0%
11.95B
52.06%
operating income
8.79B
-
7.83B
10.90%
11.76B
50.20%
14.79B
25.79%
13.43B
9.19%
15.90B
18.34%
15.90B
0%
17.16B
7.94%
18.40B
7.23%
20.07B
9.06%
6.13B
69.43%
depreciation and amortization
2.17B
-
2.60B
19.92%
2.69B
3.52%
5.77B
114.21%
3.54B
38.59%
5.47B
54.36%
5.47B
0%
4.44B
18.84%
4.87B
9.73%
4.87B
0%
167.90K
100.00%
total other income expenses net
-1.87B
-
-3.25B
73.84%
-1.43B
55.86%
-2.00B
39.62%
-1.97B
1.72%
407.34M
120.72%
2.19B
436.93%
-3.34B
252.51%
-3.99B
19.56%
-5.65B
41.79%
-5.77B
2.03%
income before tax
6.97B
-
5.94B
14.72%
10.05B
69.07%
12.60B
25.42%
10.67B
15.34%
12.58B
17.92%
12.58B
0%
13.82B
9.90%
14.41B
4.25%
14.41B
0%
364.95M
97.47%
income tax expense
1.51B
-
1.19B
21.31%
3.03B
154.40%
3.44B
13.67%
2.93B
15.02%
3.66B
25.23%
3.66B
0%
4.12B
12.58%
4.48B
8.54%
4.48B
0%
18.67B
317.19%
net income
5.42B
-
4.75B
12.35%
7.02B
47.71%
9.16B
30.46%
7.74B
15.48%
8.92B
15.17%
7.76B
12.97%
9.70B
25.01%
9.42B
2.92%
9.42B
0%
-15.02B
259.46%
weighted average shs out
271.03M
-
271.26M
0.09%
280.73M
3.49%
282.17M
0.51%
282.17M
0.00%
282.17M
0%
282.17M
0%
282.17M
0%
282.17M
0%
282.17M
0%
282.16M
0.00%
weighted average shs out dil
271.15M
-
271.36M
0.08%
280.79M
3.47%
282.25M
0.52%
282.21M
0.02%
282.18M
0.01%
282.18M
0%
282.17M
0.00%
282.17M
0%
282.17M
0%
282.16M
0.00%
eps
20.01
-
17.52
12.44%
25.01
42.75%
32.46
29.79%
27.44
15.47%
31.60
15.16%
31.60
0%
34.38
8.80%
33.37
2.94%
33.37
0%
-53.22
259.48%
epsdiluted
20
-
17.52
12.40%
25
42.69%
32.45
29.80%
27.43
15.47%
31.60
15.20%
31.60
0%
34.38
8.80%
33.37
2.94%
33.37
0%
-53.22
259.48%

All numbers in INR (except ratios and percentages)